Search research articles
Contact Us
Filters
Showing results (351-360 of 400) with videos related to
Page
of 40
Sort By:
International Journal of Nanomedicine
|
March 28, 2014
Cisplatin improves antitumor activity of weekly nab-paclitaxel in patients with metastatic breast cancer
Si Sun, Lichen Tang, Jian Zhang, et al.
Clinical and Translational Medicine
|
April 28, 2025
Myeloid deficiency of Z-DNA binding protein 1 restricts septic cardiomyopathy via promoting macrophage polarisation towards the M2-subtype
Yifan Shi, Lu He, Jie Ni, et al.
Iscience
|
October 10, 2024
Single-cell RNA sequencing and spatial transcriptomics of bladder Ewing sarcoma
Weipu Mao, Kangjie Xu, Keyi Wang, et al.
Breast Cancer Research and Treatment
|
March 30, 2010
The p21 Ser31Arg polymorphism and breast cancer risk: a meta-analysis involving 51,236 subjects
Li-Xin Qiu, Jian Zhang, Xiao-Dong Zhu, et al.
Frontiers in Bioengineering and Biotechnology
|
October 26, 2019
Cell Factory Design and Culture Process Optimization for Dehydroshikimate Biosynthesis in <i>Escherichia coli</i>
Si-Sun Choi, Seung-Yeul Seo, Sun-Ok Park, et al.
Critical Care (London, England)
|
November 20, 2014
Genetic variation in the tissue factor gene is associated with clinical outcome in severe sepsis patients
Dongwei Shi, Zhenju Song, Jun Yin, et al.
Annals of Palliative Medicine
|
September 23, 2021
Identification of soluble thrombomodulin and tissue plasminogen activator-inhibitor complex as biomarkers for prognosis and early evaluation of septic shock and sepsis-induced disseminated intravascular coagulation
Jin Zhang, Mingming Xue, Yao Chen, et al.
Translational Lung Cancer Research
|
November 14, 2025
Evaluation of gefitinib alone or combined with bevacizumab in patients with <i>EGFR</i> L858R-positive advanced non-squamous non-small cell lung cancer: an open-label, randomized, phase 2 trial (BEVA-FLFX-001) with exploratory analysis of plasma biomarkers
Xinmin Zhao, Xianghua Wu, Huijie Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
October 3, 2015
Erratum to: Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer
Bi-Yun Wang, Jian Zhang, Jia-Lei Wang, et al.
Theranostics
|
January 18, 2021
Catalytic patch with redox Cr/CeO<sub>2</sub> nanozyme of noninvasive intervention for brain trauma
Shaofang Zhang, Ying Liu, Si Sun, et al.
Page
of 40
Search research articles
Search
Showing results (351-360 of 400) with videos related to
Sort By:
Page
of 40
International Journal of Nanomedicine
|
March 28, 2014
Cisplatin improves antitumor activity of weekly nab-paclitaxel in patients with metastatic breast cancer
Si Sun, Lichen Tang, Jian Zhang, et al.
Clinical and Translational Medicine
|
April 28, 2025
Myeloid deficiency of Z-DNA binding protein 1 restricts septic cardiomyopathy via promoting macrophage polarisation towards the M2-subtype
Yifan Shi, Lu He, Jie Ni, et al.
Iscience
|
October 10, 2024
Single-cell RNA sequencing and spatial transcriptomics of bladder Ewing sarcoma
Weipu Mao, Kangjie Xu, Keyi Wang, et al.
Breast Cancer Research and Treatment
|
March 30, 2010
The p21 Ser31Arg polymorphism and breast cancer risk: a meta-analysis involving 51,236 subjects
Li-Xin Qiu, Jian Zhang, Xiao-Dong Zhu, et al.
Frontiers in Bioengineering and Biotechnology
|
October 26, 2019
Cell Factory Design and Culture Process Optimization for Dehydroshikimate Biosynthesis in <i>Escherichia coli</i>
Si-Sun Choi, Seung-Yeul Seo, Sun-Ok Park, et al.
Critical Care (London, England)
|
November 20, 2014
Genetic variation in the tissue factor gene is associated with clinical outcome in severe sepsis patients
Dongwei Shi, Zhenju Song, Jun Yin, et al.
Annals of Palliative Medicine
|
September 23, 2021
Identification of soluble thrombomodulin and tissue plasminogen activator-inhibitor complex as biomarkers for prognosis and early evaluation of septic shock and sepsis-induced disseminated intravascular coagulation
Jin Zhang, Mingming Xue, Yao Chen, et al.
Translational Lung Cancer Research
|
November 14, 2025
Evaluation of gefitinib alone or combined with bevacizumab in patients with <i>EGFR</i> L858R-positive advanced non-squamous non-small cell lung cancer: an open-label, randomized, phase 2 trial (BEVA-FLFX-001) with exploratory analysis of plasma biomarkers
Xinmin Zhao, Xianghua Wu, Huijie Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
October 3, 2015
Erratum to: Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer
Bi-Yun Wang, Jian Zhang, Jia-Lei Wang, et al.
Theranostics
|
January 18, 2021
Catalytic patch with redox Cr/CeO<sub>2</sub> nanozyme of noninvasive intervention for brain trauma
Shaofang Zhang, Ying Liu, Si Sun, et al.
Page
of 40